The top 100 most cited articles on COVID-19

Abstract

Purpose: The purpose of this study was to identify the 100 most cited publications focusing on COVID-19 to provide readers with useful historical information on current relevant research.
 Methods: A search of all databases and journals accessible in Elsevier’s Scopus was performed on May 13th, 2020. The document search was performed using query “COVID-19,” yielding 6,693 results. A similar search was performed using Thomson Reuter’s Web of Science, yielding 2,593 documents and fewer citations. The top 100 most cited papers were identified, and data were extracted. All references contained within the top 100 articles were collected. Statistical analysis was performed using R-Studio and Bibliometrix.
 Results: The top 100 most cited articles were published in 50 different journals from over 25 countries. The most cited article is “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China” by Huang et al., published in The Lancet with 1184 citations. Included are a list of the top 100 most cited articles, the most cited authors, the top five journals these publications most frequently appeared in, the most contributing countries, the top institutional affiliations, and the top international collaborations of the top 100 most
 cited publications on COVID-19.
 Conclusion: In this study, the top 100 most cited works regarding COVID-19 have been identified and analyzed. This study will serve as a historical reference for future research. This study will also provide an educational guide to facilitate effective evidence-based medical research and offer insight into the developments of COVID-19 research.
 Keywords: Scientometric, Bibliometric, COVID-19, Coronavirus

Optimal COVID-19 Vaccine Sharing Between Two Nations That Also Have Extensive Travel Exchanges

“…We modify the nation one vaccine group to account for the lowering of immunity, by adding an extra loss term of −σ V V 1 to the right hand side of Equation (4). A balancing gain term of +σ V V 1 is added to the susceptible group S 1 , given by Equation (1). Similar changes can be made to the nation two equations for V 2 and S 2 .…”

“…Through 2020, countries across the world have worked to diminish the impact of the SARS-CoV-2 virus and lower the related levels of COVID-19 illness (1). Initially, these control measures have included the implementation of non-pharmaceutical interventions (NPIs) to keep people apart, such as "social distancing" policies of limited socialising, or "lockdowns" whereby citizens are instructed to remain at home.…”